Skip to Main Content

Paper Details

Sub-myeloablative Second Transplantations with Haploidentical Donors and Post-Transplant Cyclophosphamide have limited Anti-Leukemic Effects in Pediatric Patients.
Transplant Cell Ther
1
2022
Cyclophosphamide, GVHD, NK cell, Participants, Patients, Pediatric, anti-thymocyte globulin, busulfan, clofarabine, cyclophosphamide, cytarabine, graft-versus-host disease, graft-versus-leukemia, hematologic malignancies, high-, leukemic blasts, natural killer (NK) cell, neutrophil, participants, patient, patients, plerixafor
Author NameAffiliation
Yongjin LiSt. Jude Children's Research Hospital
Yongjin LiSt. Jude Children's Research Hospital
Cheng ChengSt. Jude Children's Research Hospital
  • 1 - 3

Datasets

Release 1.2